By contrast, MBCs associated with BRCA2 PVs display specific pathologic features suggestive of an aggressive phenotype, such as higher histologic grade, compared both with FBC in BRCA2 PV carriers and with MBC in the general population [12,80,81]. This evidence concerns the gene BRCA2 and maternal uniparental disomy of chromosome 20.